MARS Bioimaging Ltd

spectral CT for biomedical imaging

Anthony Butler

www.marsbioimaing.com

Founded 2008:

Spin out of University of Canterbury

Exclusive licence for CERN Medipix3 detector technology

Own all IP relating spectral CT from the university

Products:

MARS scanners: Medipix3 based microCT system

MARS camera: Medipix3 detector and readout for integration into 3rd party CTs

Overview

Technology and its uses

Xray source

MAR

S sp

ectr

al C

T

Medipix

Colordetectors

Spectral CT is now possible

Medipix All Resolution System

Energy resolution

Spatial resolution

Temporal resolution

Cartilage

Bone

Low GAG

MBI Products

MARS scanner

microCT for small animal and pathology researcher

MARS Medipix3 camera

Up to 8 Simultaneous energies

55µm or 110 µm pixel pitch resolution

1 to 6 Medipix chips (28x52mm array)

Silicon or CdTe/CZT

Excellent energy resolution ( Charge sharing compensation )

Image of PCB taken with Medipix3 Si-quad, 28x28mm

Medipix3 camera system

for integration into 3rd party systems

MBI Company information

Market strategy

Get MARS systems to key opinion leader’s labs

Enable researchers using MARS tool to validate spectral CT

Provide camera units for existing pre-clinical manufacturers to integrate into their systems

Leverage pre-clinical adoption to find partner for human imaging

MARS project structure

MARS is the technology

MARS Bioimaging Ltdaka. “MBI”

Commercial outlet for NZ’s R+D

Research teamsUniversity of Canterbury

University of Otago

MARS project structure

MARS Bioimaging Ltdaka. “MBI”

Commercial outlet for NZ’s R+D

Shareholders University of Canterbury Individual scientist Private investors

MARS IP structure

MARS Bioimaging Ltd

Medipix3 Collaboration

University of Canterbury

University of Otago

Exclusive license forsmall animal and human CT

All IP relating to spectral CTtechnology

Sub-contract for pre-clinical research

MARS Funding structure

MARS Bioimaging Ltd

Medipix3 Collaboration

University of Canterbury

University of Otago

Investment

MARS Funding structure

MARS Bioimaging Ltd

Medipix3 Collaboration

University of Canterbury

University of Otago

InvestmentSales

MARS Funding structure

MARS Bioimaging Ltd

Medipix3 Collaboration

University of Canterbury

University of Otago

InvestmentSales

Contribution to Medipix3 development

Scholarship funding

MARS Funding structure

MARS Bioimaging Ltd

Medipix3 Collaboration

University of Canterbury

University of Otago

InvestmentSales

Scholarship funding

NZ government funding

Contribution to Medipix3 development

Why would a researcher do this?

Government instruction

80% of NZ government funding is aimed at economic return

Key concept is international revenue

Want a route to market early in an R+D program

Benefit to research

Provides direction and focus

Get the technology into users hands early

Provides new funding routes

Personal

Satisfaction – your research is used!!!

New challenges

Personal

Satisfaction – your research is used!!!

New challenges

Potential for financial gain…

…. but I’m a radiologist!!

Summary

MARS-CT make spectral CT possible

Early adopters already purchasing

www.marsbioimaging.com